Viewing nowCombinationLevomos 5/40 mg
Olmesartan Medoxomil · S-Amlodipine Besylate 2.5 Hydrate
Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.

MFDS item code 201405839 · Approved 2014.12.10 · Insurance code 650204260
Improvement of blood pressure control in essential hypertension
S-Amlodipine or Olmesartan Medoxomil monotherapy is used for adequate blood pressure control in patients with essential hypertension. These medications help lower blood pressure and prevent cardiovascular complications. They effectively stabilize blood pressure even when control is difficult, thus playing an important role in managing essential hypertension.
This medication should be taken once daily, with 1 tablet with water, regardless of meals. It is recommended to take it at the same time every day (e.g., in the morning). The recommended dosages are 2.5/20 mg, 2.5/40 mg, and 5/40 mg, and each dosage can be gradually increased based on blood pressure response. Adjustments should be made for patients with renal impairment, reduced effective blood volume, liver impairment, and elderly patients.
The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and neonate when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It is contraindicated in individuals allergic to this medication or its components, pregnant or breastfeeding women, patients with severe liver disease or aortic stenosis, patients with bile duct obstruction, patients on dialysis, shock state patients, and certain diabetic patients. In hypotensive patients with inadequate fluid or salt, there may be a risk of hypotension upon initial use, and their condition should be closely monitored. Appropriate measures should be taken if blood pressure decreases too much. Because of the possibility of rapid vascular dilation leading to hypotension, it should be used cautiously in patients with aortic stenosis, obstructive coronary artery disease, or congestive heart failure. Patients with impaired renal function may experience further deterioration of kidney function, and caution is advised for patients with impaired liver function as well. While taking this medication, various side effects such as dizziness, headache, hypotension, edema, dyspepsia, rash, etc., may occur. If any abnormal symptoms arise, consultation with healthcare professionals is important. In particular, it is advisable to avoid taking this medication with grapefruit juice as this can lead to excessive blood pressure-lowering effects. Women who are pregnant or planning to become pregnant are recommended to switch to other antihypertensive medications that have demonstrated safety instead of this drug. Women who are breastfeeding should discontinue either breastfeeding or this medication, as there is a possibility that it may be transmitted through breast milk and affect the infant. It is not advisable to use this medication in children under 18 years of age, as its safety and efficacy have not been established. Older adults may experience decreased liver, kidney, and heart function, so they should start with a low dose and be prescribed with caution. In case of overdose, hypotension and cardiac arrhythmias may occur, requiring immediate treatment and blood pressure monitoring. This medication should be stored in a tightly closed container to prevent exposure to light and moisture, and kept out of reach of children. Transfers to other containers should be avoided.
Urticaria, severe swelling (edema), difficulty breathing, serious allergic reactions, severe skin reactions, jaundice, liver dysfunction, severe neurological symptoms, significantly reduced urine output, severe swelling or urination abnormalities, angioedema, rhabdomyolysis, acute renal failure, hair loss, itching, autoimmune hepatitis, toxic epidermal necrolysis, myocardial infarction, stroke, intestinal vascular edema, chronic malabsorption syndrome (sprue)-like intestinal disease, acute renal failure,
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering and kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.
Reddish-brown round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil · S-Amlodipine Besylate 2.5 Hydrate
Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Dongkuk Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.